Associated Papers
Integration of genetic fine-mapping and multi-omics data reveals candidate effector genes for hypertension.
van Duijvenboden S et al.
American Journal of Human Genetics, 2023
Rare and common genetic determinants of metabolic individuality and their effects on human health.
Surendran P et al.
Nature Medicine, 2022
Dopamine beta-hydroxylase and its genetic variants in human health and disease.
Gonzalez-Lopez E et al.
Journal of Neurochemistry, 2020
A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme.
Gonzalez-Lopez E et al.
Plos One, 2019
Characterization of SNPs in the dopamine-β-hydroxylase gene providing new insights into its structure-function relationship.
Punchaichira TJ et al.
Neurogenetics, 2017
Deep sequencing identifies novel regulatory variants in the distal promoter region of the dopamine-β-hydroxylase gene.
Punchaichira TJ et al.
Pharmacogenetics and Genomics, 2016
The contribution of rare and common variants in 30 genes to risk nicotine dependence.
Yang J et al.
Molecular Psychiatry, 2015
Structural insight of dopamine β-hydroxylase, a drug target for complex traits, and functional significance of exonic single nucleotide polymorphisms.
Kapoor A et al.
Plos One, 2011
Select a paper to view details